Choi Jaesoon
CEO

LN Robotics develops AVIAR, Korea's first vascular interventional robot designed to assist in percutaneous coronary interventions while significantly reducing radiation exposure for both clinicians and patients. By integrating clinical expertise and big data from leading hospitals, the company enhances the precision and safety of cardiovascular procedures.
Funding not disclosed

CEO
During percutaneous coronary interventions (PCIs), clinicians are exposed to significant radiation, posing health risks despite protective measures. Traditional PCI procedures also demand a high degree of precision and can be physically taxing for the interventional cardiologist.
LN Robotics has developed AVIAR, a vascular interventional robot designed to assist clinicians during PCI procedures, significantly reducing their radiation exposure. AVIAR enhances the precision and safety of cardiovascular procedures through its robotic arm and control system. The system integrates clinical expertise and procedural data from leading hospitals to optimize workflow and improve patient outcomes. By automating key steps and providing enhanced visualization, AVIAR aims to improve the efficiency and consistency of PCI procedures.
The primary target audience includes interventional cardiologists, hospitals, and cardiac catheterization labs seeking to reduce radiation exposure, improve procedural precision, and enhance the efficiency of PCI procedures.